BenzingaFri, 10 Apr 2026 18:45:56 GMTCue Biopharma Receives $7.5M Milestone Payment From Boehringer IngelheimCUE-2.04%
Seeking AlphaTue, 07 Apr 2026 20:56:09 GMTCue Biopharma, Inc. (CUE) Discusses CUE-401 R&D Progress and Mechanism for Autoimmune and Inflammatory Diseases TranscriptCUE-2.04%